Research Article
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines
Figure 15
Determination of MDA and GR activity after treatment of the HepG2 cell line (a) with IC50 of some newly synthesized chalcone-thienopyrimidines (3a, 3b, 3c, 3d, 3e, and 3g) and the MCF-7 cell line (b) with IC50 of some newly synthesized chalcone-thienopyrimidine (3a and 3g) derivatives in comparison to the traditional anticancer drug 5-FU. Data were expressed for each bar as . from control, # from 5FU.
(a) |
(b) |